We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Dupont Nutrition Hit With Form 483 for Faulty Practices and Missing Information
Dupont Nutrition Hit With Form 483 for Faulty Practices and Missing Information
The FDA slapped Dupont Nutrition’s excipient manufacturing facility in Newark, Del., with an eight-observation Form 483 following an inspection in November to December 2021 that revealed inadequate procedures and other quality lapses.